ASCLX
Price
$13.56
Change
-$0.04 (-0.29%)
Updated
Aug 15 closing price
Net Assets
1.55B
DIAMX
Price
$28.71
Change
-$0.06 (-0.21%)
Updated
Aug 15 closing price
Net Assets
1.94B
Interact to see
Advertisement

ASCLX vs DIAMX

Header iconASCLX vs DIAMX Comparison
Open Charts ASCLX vs DIAMXBanner chart's image
AB Select US Long/Short C
Price$13.56
Change-$0.04 (-0.29%)
VolumeN/A
Net Assets1.55B
Diamond Hill Long-Short I
Price$28.71
Change-$0.06 (-0.21%)
VolumeN/A
Net Assets1.94B
ASCLX vs DIAMX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ASCLX vs. DIAMX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASCLX is a Buy and DIAMX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DIAMX has more cash in the bank: 1.95B vs. ASCLX (1.56B). DIAMX pays higher dividends than ASCLX: DIAMX (1.90) vs ASCLX (0.00). ASCLX was incepted earlier than DIAMX: ASCLX (13 years) vs DIAMX (25 years). ASCLX (2.76) is less costly to investors than DIAMX (1.75). ASCLX is a more actively managed with annual turnover of: 242.00 vs. DIAMX (46.00). ASCLX (2500) and DIAMX (2500) have matching initial minimum investment requirements. DIAMX annual gain was more profitable for investors over the last year : 3.15 vs. ASCLX (2.65). DIAMX return over 5 years is better than : 26.16 vs. ASCLX (9.46).
ASCLXDIAMXASCLX / DIAMX
Total Expense Ratio2.711.75155%
Annual Report Gross Expense Ratio2.761.75158%
Fund Existence13 years25 years-
Gain YTD5.60710.00056%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets1.56B1.95B80%
Annual Yield % from dividends0.001.90-
Returns for 1 year2.653.1584%
Returns for 3 years11.1611.08101%
Returns for 5 years9.4626.1636%
Returns for 10 years15.6225.6061%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ENZN0.08N/A
+3.95%
Enzon Pharmaceuticals, Inc.
SDVKY25.130.11
+0.44%
Sandvik AB
PHCCF5.98N/A
N/A
PHC Holdings Corp.
CMCAF11.40N/A
N/A
Capitalworks Emerging Markets Acquisition Corp
QUBHF2.42N/A
N/A
Qube Hldgs Ltd